Adma Biologics (ADMA) Research & Development (2011 - 2025)
Adma Biologics (ADMA) reported Research & Development of $1.4 million for Q4 2025, up 251.92% on a YoY basis from $391000.0 in Q4 2024, and down 9.95% quarter-over-quarter from $1.5 million in Q3 2025.
Adma Biologics (ADMA) Research & Development (2011 - 2025) Analysis & Trends
Adma Biologics has reported Research & Development for 13 years, with the latest figure at $1.4 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 251.92% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $4.8 million (up 162.6% YoY), and the FY2025 full-year result was $4.8 million, up 162.66% from the prior year.
- Research & Development for Q4 2025 stood at $1.4 million, down from $1.5 million in the prior quarter.
- The five-year high for Research & Development was $1.5 million in Q3 2025, with the low at $391000.0 in Q4 2024.
- Historically, Research & Development has averaged $856700.0 across 5 years, with a median of $840500.0 in 2023.
- Annual changes were most pronounced in 2024 — Research & Development sank 60.09% — and 2025, when it soared 270.87%.
- Adma Biologics' Research & Development stood at $728928.0 in 2021, then jumped by 47.42% to $1.1 million in 2022, then tumbled by 58.49% to $446000.0 in 2023, then declined by 12.33% to $391000.0 in 2024, then jumped by 251.92% to $1.4 million in 2025.
- The last three Research & Development figures came in at $1.4 million (Q4 2025), $1.5 million (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 826,000.00 |
| Dec 31, 2024 | 391,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 560,000.00 |
| Mar 31, 2024 | 450,000.00 |
| Dec 31, 2023 | 446,000.00 |
| Sep 30, 2023 | 596,000.00 |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 855,000.00 |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 873,386.00 |
| Mar 31, 2022 | 624,111.00 |
| Dec 31, 2021 | 728,928.00 |
| Sep 30, 2021 | 770,557.00 |
| Jun 30, 2021 | 1.16 Mn |
| Mar 31, 2021 | 987,649.00 |